Liminatus Pharma, Inc. (LIMN) › Operating IncomeLiminatus Pharma, Inc. (LIMN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2024: -$3.33M2025: -$2.97M-$2.97M2024Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$2.97M+10.9%2024-$3.33M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share